THE Australian Competition &
Consumer Commission (ACCC) should
explore the scope for ‘meaningful
penalties’ which could be included
in the Medicines Australia Code of
Conduct, 17th edition.
The comments come as part of a
submission to the ACCC regarding
the updated Code from Bruce
Arnold, Lecturer at the University
of Canberra’s School of Law.
“It is clear that leading
corporations that are expected to
participate in the Code have
engaged in egregious bad practice
(signalled for example by the recent
multi-billion dollar settlement in
involving GlaxoSmithKline),” he ...
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 06 Aug 12
Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country. MORE